All Pharma News
Biocon Biologics gears up to challenge Stelara in the US

Biocon Biologics gears up to challenge Stelara in the US
Eric Sagonowsky FIERCE PHARMA
29 Feb 2024
Share Share
Biocon Biologics focusing on market share gains of biosimilars in key markets

Biocon Biologics focusing on market share gains of biosimilars in key markets
ECONOMIC TIMES
13 Feb 2024
Share Share
Biocon Concludes Integration of Biosimilars Business in 120 countries

Biocon Concludes Integration of Biosimilars Business in 120 countries
PR NEWSWIRE
18 Dec 2023
Share Share
Biocon Biologics recognized as an Asia IP Elite for 2023

Biocon Biologics recognized as an Asia IP Elite for 2023
INDIAN PHARMA POST
17 Dec 2023
Share Share
Biocon Biologics Completes Integration of Viatris™ Biosimilar Business

Biocon Biologics Completes Integration of Viatris™ Biosimilar Business
GLOBENEWSWIRE
30 Nov 2023
Share Share
Biocon Biologics receives MHRA Approval for Biosimilar Aflibercept ‘Yesafili’

Biocon Biologics receives MHRA Approval for Biosimilar Aflibercept ‘Yesafili’
INDIAN PHARMA POST
14 Nov 2023
Share Share
Biocon Biologics announces divestment of two non-core branded formulations

Biocon Biologics announces divestment of two non-core branded formulations
INDIAN PHARMA POST
09 Nov 2023
Share Share
Biocon Biologics names Kedar Upadhye as new CFO

Biocon Biologics names Kedar Upadhye as new CFO
ECONOMIC TIMES
19 Oct 2023
Share Share
Biocon`s Malaysia insulin facility classified by FDA for official action

Biocon`s Malaysia insulin facility classified by FDA for official action
ECONOMIC TIMES
18 Oct 2023
Share Share
On track to integrate major part Viatris``acquired biosimilars biz this fiscal

On track to integrate major part Viatris``acquired biosimilars biz this fiscal
ECONOMICTIMES
30 Aug 2023
Share Share